tiprankstipranks
3 Best Stocks to Buy Now, 3/1/2024, According to Top Analysts 
PremiumMarket News3 Best Stocks to Buy Now, 3/1/2024, According to Top Analysts 
2M ago
SpringWorks Therapeutics announces EMA validaion for nirogacestat MAA
PremiumThe Fly
SpringWorks Therapeutics announces EMA validaion for nirogacestat MAA
2M ago
SpringWorks Therapeutics Announces European Medicines Agency Validation for Marketing Authorization Application of Nirogacestat for the Treatment of Adults with Desmoid Tumors
PremiumPress Releases
SpringWorks Therapeutics Announces European Medicines Agency Validation for Marketing Authorization Application of Nirogacestat for the Treatment of Adults with Desmoid Tumors
2M ago
SpringWorks Therapeutics price target raised to $70 from $60 at Wedbush
PremiumThe FlySpringWorks Therapeutics price target raised to $70 from $60 at Wedbush
2M ago
SpringWorks Therapeutics to Present at Upcoming Investor Conferences
PremiumPress Releases
SpringWorks Therapeutics to Present at Upcoming Investor Conferences
2M ago
SpringWorks Therapeutics to Present at Upcoming Investor Conferences
PremiumPress Releases
SpringWorks Therapeutics to Present at Upcoming Investor Conferences
2M ago
JPMorgan ups SpringWorks target, adds to Analyst Focus List
PremiumThe FlyJPMorgan ups SpringWorks target, adds to Analyst Focus List
3M ago
SpringWorks Therapeutics Highlights 2023 Accomplishments and Anticipated Milestones for 2024 at the 42nd Annual J.P. Morgan Healthcare Conference
PremiumPress Releases
SpringWorks Therapeutics Highlights 2023 Accomplishments and Anticipated Milestones for 2024 at the 42nd Annual J.P. Morgan Healthcare Conference
4M ago
SpringWorks Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
PremiumPress Releases
SpringWorks Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100